Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/18/11 | 8-K | Current report filing |
|
4 | |
| 08/15/11 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
36 |
| 07/27/11 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/22/11 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/14/11 | EFFECT | Notice of Effectiveness |
|
1 | |
| 07/14/11 | 424B4 | Prospectus filed pursuant to Rule 424(b)(4) |
|
96 | |
| 07/13/11 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
8 | |
| 07/13/11 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 07/13/11 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
5 | |
| 07/07/11 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
